发明名称 Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion
摘要 An ophthalmic solution is provided. The ophthalmic solution is hypertonic. The ophthalmic solution includes a polysaccharide having an average molecular weight of between about 40,000 grams per mole and about 150,000 grams per mole. A packaged ophthalmic solution for preventing the ophthalmic solution from being exposed to CO2 and other contaminants is also provided. The ophthalmic solution can be used to treat recurrent corneal erosion. The ophthalmic solution can also be used as a prophylactic to prevent recurrent corneal erosion.
申请公布号 US9636355(B2) 申请公布日期 2017.05.02
申请号 US201113200270 申请日期 2011.09.22
申请人 Theo Holdings, LLC 发明人 Szabocsik John M.
分类号 A61K9/08;A61K31/721;A61K31/728;A61K31/715;A61K9/00;A61J1/06 主分类号 A61K9/08
代理机构 Hinshaw & Culbertson LLP 代理人 Hinshaw & Culbertson LLP
主权项 1. An ophthalmic solution for treating and preventing recurrent corneal erosion consisting essentially of: between about 5% and 25% by weight of non-substituted glucose polymer having an average molecular weight of between about 40,000 grams per mole and about 150,000 grams per mole; between about 0.5% and 2% by weight NaCl; between about 0.5% and 2% by weight hyaluronic acid; between about 71% and 94% by weight H2O; and optionally an anesthetic; wherein the ophthalmic solution is an aqueous solution having a viscosity of between about 6.5 and 7.5 centistokes, has a pH between about 6.5 and 7.5, has an osmolality of between about 320-350 mOsmol/kg solution and a colloidal osmolality at least equal to the colloidal osmolality of the deturgescent cornea.
地址 Cohasset MA US